Search details
1.
Objective and Subjective Measures of Premature Ejaculation: How Closely Do They Correspond and How Well Are the Subjective Measures Recalled?
J Sex Med
; 17(4): 634-644, 2020 04.
Article
in English
| MEDLINE | ID: mdl-32089486
2.
The Oxytocin Antagonist Cligosiban Fails to Prolong Intravaginal Ejaculatory Latency in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Phase IIb trial (PEDRIX).
J Sex Med
; 16(8): 1188-1198, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31351660
3.
Pharmacokinetics, Safety, and Tolerability of Multiple Doses of the Novel Oxytocin Receptor Antagonist Cligosiban in Development for Premature Ejaculation: Two Randomized Clinical Trials in Healthy Subjects.
J Sex Med
; 16(2): 213-222, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30612858
4.
The Oxytocin Antagonist Cligosiban Prolongs Intravaginal Ejaculatory Latency and Improves Patient-Reported Outcomes in Men with Lifelong Premature Ejaculation: Results of a Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Trial (PEPIX).
J Sex Med
; 16(8): 1178-1187, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31351659
5.
Pharmacokinetics, Safety, and Tolerability of Single Oral Doses of a Novel Oxytocin Receptor Antagonist-Cligosiban-in Development for Premature Ejaculation: Three Randomized Clinical Trials in Healthy Subjects.
J Sex Med
; 15(11): 1547-1557, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30341006
6.
Response to Letter to the Editor Regarding "Cligosiban for Premature Ejaculation: Success, Failure, or Insufficiently Tested?"
J Sex Med
; 16(11): 1864-1865, 2019 11.
Article
in English
| MEDLINE | ID: mdl-31672288
7.
Effect of maraviroc on the pharmacokinetics of midazolam, lamivudine/zidovudine, and ethinyloestradiol/levonorgestrel in healthy volunteers.
Br J Clin Pharmacol
; 65 Suppl 1: 19-26, 2008 Apr.
Article
in English
| MEDLINE | ID: mdl-18333862
8.
The effects of cotrimoxazole or tenofovir co-administration on the pharmacokinetics of maraviroc in healthy volunteers.
Br J Clin Pharmacol
; 65 Suppl 1: 47-53, 2008 Apr.
Article
in English
| MEDLINE | ID: mdl-18333865
9.
A novel probe drug interaction study to investigate the effect of selected antiretroviral combinations on the pharmacokinetics of a single oral dose of maraviroc in HIV-positive subjects.
Br J Clin Pharmacol
; 65 Suppl 1: 54-9, 2008 Apr.
Article
in English
| MEDLINE | ID: mdl-18333866
10.
Effects of CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers.
Br J Clin Pharmacol
; 65 Suppl 1: 27-37, 2008 Apr.
Article
in English
| MEDLINE | ID: mdl-18333863
11.
Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers.
Br J Clin Pharmacol
; 65 Suppl 1: 38-46, 2008 Apr.
Article
in English
| MEDLINE | ID: mdl-18333864
12.
Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers.
Br J Clin Pharmacol
; 65 Suppl 1: 5-18, 2008 Apr.
Article
in English
| MEDLINE | ID: mdl-18333861
13.
The Karolinska cocktail for phenotyping of five human cytochrome P450 enzymes.
Clin Pharmacol Ther
; 73(6): 517-28, 2003 Jun.
Article
in English
| MEDLINE | ID: mdl-12811361
14.
Species differences in the disposition of the CCR5 antagonist, UK-427,857, a new potential treatment for HIV.
Drug Metab Dispos
; 33(4): 587-95, 2005 Apr.
Article
in English
| MEDLINE | ID: mdl-15650075
15.
Pharmacokinetics of sildenafil after single oral doses in healthy male subjects: absolute bioavailability, food effects and dose proportionality.
Br J Clin Pharmacol
; 53 Suppl 1: 5S-12S, 2002.
Article
in English
| MEDLINE | ID: mdl-11879254
16.
The effects of sildenafil on human sperm function in healthy volunteers.
Br J Clin Pharmacol
; 53 Suppl 1: 53S-60S, 2002.
Article
in English
| MEDLINE | ID: mdl-11879260
17.
Comparative human pharmacokinetics and metabolism of single-dose oral and intravenous sildenafil.
Br J Clin Pharmacol
; 53 Suppl 1: 13S-20S, 2002.
Article
in English
| MEDLINE | ID: mdl-11879255
18.
The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.
Br J Clin Pharmacol
; 53 Suppl 1: 21S-30S, 2002.
Article
in English
| MEDLINE | ID: mdl-11879256
19.
The effects of steady-state erythromycin and azithromycin on the pharmacokinetics of sildenafil in healthy volunteers.
Br J Clin Pharmacol
; 53 Suppl 1: 37S-43S, 2002.
Article
in English
| MEDLINE | ID: mdl-11879258
20.
The pharmacokinetics and hemodynamics of sildenafil citrate in male hemodialysis patients.
Kidney Int
; 66(1): 367-74, 2004 Jul.
Article
in English
| MEDLINE | ID: mdl-15200445
Results
1 -
20
de 20
1
Next >
>>